|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1996-7-25
|
|
pubmed:abstractText |
This United Kingdom Medical Research Council (UK-MRC) study prospectively evaluated efficacy and long-term toxicity of adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis (NSGCTT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1106-13
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8648364-Adult,
pubmed-meshheading:8648364-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8648364-Bleomycin,
pubmed-meshheading:8648364-Chemotherapy, Adjuvant,
pubmed-meshheading:8648364-Cisplatin,
pubmed-meshheading:8648364-Drug Administration Schedule,
pubmed-meshheading:8648364-Dysgerminoma,
pubmed-meshheading:8648364-Etoposide,
pubmed-meshheading:8648364-Humans,
pubmed-meshheading:8648364-Male,
pubmed-meshheading:8648364-Neoplasm Invasiveness,
pubmed-meshheading:8648364-Neoplasm Staging,
pubmed-meshheading:8648364-Orchiectomy,
pubmed-meshheading:8648364-Prognosis,
pubmed-meshheading:8648364-Risk Factors,
pubmed-meshheading:8648364-Testicular Neoplasms,
pubmed-meshheading:8648364-Time Factors,
pubmed-meshheading:8648364-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.
|
|
pubmed:affiliation |
Birmingham Oncology Centre, Queen Elizabeth Hospital, Birmingham, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
